Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has agreed to pay Roche $36 million to resolve a patent infringement lawsuit over Tandem’s t:slim X2 insulin pump. The deal settles all pending and ...

Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further ...

Roche earned $5.8 billion from the sale of risdiplam in the 2021-2024 period, about 115 times the calculated cost.

Roche moves to mitigate US tariff impact amid discussions with global governments By Angus Liu Apr 24, 2025 10:48am Roche Thomas Schinecker pharma CEO tariffs ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...

Basel, Switzerland-based Roche currently maintains 13 manufacturing and 15 R&D sites in the U.S. across its pharmaceutical and diagnostics divisions. These sites employ more than 25,000.

This investment plan is expected to create over 12,000 new jobs, with a thousand at Roche and the remaining 11,000 to serve as support for the new facilities, in addition to 6,500 construction jobs.

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.

Roche anticipates tests being available in Europe by late 2025, with the U.S. following. Price Action: RHHBY stock closed lower by 4.37% to $37.65 on Friday. Read Next: ...

Roche doesn’t just want to win Western States and set a course record; he also wants to do it in the way he wants to, with his own mix of self-experimentation and science. It’s a recipe that ...

Investors largely appeared to share Steensberg’s optimism. Shares of Zealand traded on Nasdaq Copenhagen surged 38% from DKK 488.80 ($71.54) to an even DKK 674 ($98.38), while Roche shares ...